fenoldopam has been researched along with Kidney Failure in 13 studies
Fenoldopam: A dopamine D1 receptor agonist that is used as an antihypertensive agent. It lowers blood pressure through arteriolar vasodilation.
Kidney Failure: A severe irreversible decline in the ability of kidneys to remove wastes, concentrate URINE, and maintain ELECTROLYTE BALANCE; BLOOD PRESSURE; and CALCIUM metabolism.
| Excerpt | Relevance | Reference |
|---|---|---|
| "0 microg kg(-1) min(-1)) or saline on renal blood flow and function in 10 anaesthetized Labrador dogs in whom rhabdomyolysis and myoglobinuric acute renal failure had been induced by administration of glycerol 50% (10mL kg(-1)) intramuscularly." | 7.72 | Effects of fenoldopam on renal blood flow and its function in a canine model of rhabdomyolysis. ( Corcoran, T; Markos, F; Murray, C; Parfrey, N; Shorten, GD; Snow, HM, 2003) |
| "0 microg kg(-1) min(-1)) or saline on renal blood flow and function in 10 anaesthetized Labrador dogs in whom rhabdomyolysis and myoglobinuric acute renal failure had been induced by administration of glycerol 50% (10mL kg(-1)) intramuscularly." | 3.72 | Effects of fenoldopam on renal blood flow and its function in a canine model of rhabdomyolysis. ( Corcoran, T; Markos, F; Murray, C; Parfrey, N; Shorten, GD; Snow, HM, 2003) |
| " Median contrast dosage was 120 mL (range 50-200)." | 2.73 | Targeted renal therapy and contrast-induced nephropathy during endovascular abdominal aortic aneurysm repair: results of a feasibility pilot trial. ( Allie, DE; Hebert, CJ; Keller, VA; Lirtzman, MD; Mitran, EV; Patlola, R; Veerina, KK; Walker, CM; Wyatt, CH, 2007) |
| "Acute renal failure is a serious complication of cardiac surgery causing high morbidity and mortality." | 2.71 | Renoprotective action of fenoldopam in high-risk patients undergoing cardiac surgery: a prospective, double-blind, randomized clinical trial. ( Aletti, G; Bove, T; Calabrò, MG; Cerchierini, E; Crescenzi, G; Landoni, G; Marino, G; Zangrillo, A, 2005) |
| "Fenoldopam mesylate is a novel, highly selective dopamine type-1 agonist that preferentially dilates the renal and splanchnic vasculature, but has not been investigated in patients undergoing prolonged aortic clamping for whom adverse renal outcomes should be more likely." | 2.70 | Fenoldopam infusion associated with preserving renal function after aortic cross-clamping for aneurysm repair. ( Benjamin, ME; Flinn, WR; Gilbert, TB; Hasnain, JU; Lilly, MP, 2001) |
| " The following manuscript outlines the commonly used pharmacologic agents for perioperative BP including dosing regimens and adverse effect profiles." | 2.66 | Pharmacologic Control of Blood Pressure in Infants and Children. ( Krawczeski, CD; Naguib, A; Simsic, J; Tobias, JD, 2020) |
| "Acute renal failure/acute kidney injury is classified according to the RIFLE criteria where a change from baseline serum creatinine or urine output determines the level of renal dysfunction." | 2.44 | Acute renal failure. ( Kellum, JA; Leblanc, M; Venkataraman, R, 2008) |
| " TRT, the delivery of therapeutic agents directly to the kidneys by renal arterial infusion, has the advantage of providing a higher local effective dose with potentially greater renal effects, while limiting systemic adverse effects due to renal first-pass elimination." | 1.35 | Safety and performance of targeted renal therapy: the Be-RITe! Registry. ( Allie, DE; Cohen, MG; Danna, P; Fearon, WF; Filby, SJ; Findeiss, L; Kyriazis, D; Leon, MB; Mehran, R; Moses, JW; Price, MJ; Sachdev, N; Teirstein, PS; Vora, K; Walker, CM; Weinstock, BS; Weisz, G; Wiechmann, BN, 2009) |
| "No patient developed renal failure that required dialysis, whereas 7." | 1.32 | A case series of low-dose fenoldopam in seventy cardiac surgical patients at increased risk of renal dysfunction. ( Davis, EA; Garwood, S; Hines, RL; Samson, L; Swamidoss, CP, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (7.69) | 18.2507 |
| 2000's | 11 (84.62) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (7.69) | 2.80 |
| Authors | Studies |
|---|---|
| Tobias, JD | 1 |
| Naguib, A | 1 |
| Simsic, J | 1 |
| Krawczeski, CD | 1 |
| Weisz, G | 1 |
| Filby, SJ | 1 |
| Cohen, MG | 1 |
| Allie, DE | 2 |
| Weinstock, BS | 1 |
| Kyriazis, D | 1 |
| Walker, CM | 2 |
| Moses, JW | 1 |
| Danna, P | 1 |
| Fearon, WF | 1 |
| Sachdev, N | 1 |
| Wiechmann, BN | 1 |
| Vora, K | 1 |
| Findeiss, L | 1 |
| Price, MJ | 1 |
| Mehran, R | 1 |
| Leon, MB | 1 |
| Teirstein, PS | 1 |
| Boyle, JR | 1 |
| Kellum, JA | 1 |
| Leblanc, M | 1 |
| Venkataraman, R | 1 |
| Garwood, S | 1 |
| Swamidoss, CP | 1 |
| Davis, EA | 1 |
| Samson, L | 1 |
| Hines, RL | 1 |
| Thompson, EJ | 1 |
| King, SL | 1 |
| Murray, C | 1 |
| Markos, F | 1 |
| Snow, HM | 1 |
| Corcoran, T | 1 |
| Parfrey, N | 1 |
| Shorten, GD | 2 |
| Bove, T | 1 |
| Landoni, G | 1 |
| Calabrò, MG | 1 |
| Aletti, G | 1 |
| Marino, G | 1 |
| Cerchierini, E | 1 |
| Crescenzi, G | 1 |
| Zangrillo, A | 1 |
| Lirtzman, MD | 1 |
| Wyatt, CH | 1 |
| Keller, VA | 1 |
| Mitran, EV | 1 |
| Hebert, CJ | 1 |
| Patlola, R | 1 |
| Veerina, KK | 1 |
| Shusterman, NH | 1 |
| Elliott, WJ | 1 |
| White, WB | 1 |
| Gilbert, TB | 1 |
| Hasnain, JU | 1 |
| Flinn, WR | 1 |
| Lilly, MP | 1 |
| Benjamin, ME | 1 |
| Madyoon, H | 1 |
| Croushore, L | 1 |
| Weaver, D | 1 |
| Mathur, V | 1 |
| Halpenny, M | 1 |
| Rushe, C | 1 |
| Breen, P | 1 |
| Cunningham, AJ | 1 |
| Boucher-Hayes, D | 1 |
3 reviews available for fenoldopam and Kidney Failure
| Article | Year |
|---|---|
Pharmacologic Control of Blood Pressure in Infants and Children.
Topics: Adolescent; Adrenergic beta-Antagonists; Antihypertensive Agents; Blood Pressure; Calcium Channel Bl | 2020 |
Acute renal failure.
Topics: Acetylcysteine; Acute Kidney Injury; Fenoldopam; Humans; Renal Dialysis; Renal Insufficiency; Renal | 2008 |
Acetylcysteine and fenoldopam. Promising new approaches for preventing effects of contrast nephrotoxicity.
Topics: Acetylcysteine; Antioxidants; Contrast Media; Drug Administration Routes; Drug Administration Schedu | 2003 |
5 trials available for fenoldopam and Kidney Failure
| Article | Year |
|---|---|
Renoprotective action of fenoldopam in high-risk patients undergoing cardiac surgery: a prospective, double-blind, randomized clinical trial.
Topics: Aged; Cardiac Surgical Procedures; Dopamine; Dopamine Agonists; Double-Blind Method; Female; Fenoldo | 2005 |
Targeted renal therapy and contrast-induced nephropathy during endovascular abdominal aortic aneurysm repair: results of a feasibility pilot trial.
Topics: Aged; Aortic Aneurysm, Abdominal; Blood Vessel Prosthesis Implantation; Contrast Media; Dopamine Ago | 2007 |
Fenoldopam, but not nitroprusside, improves renal function in severely hypertensive patients with impaired renal function.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Adult; Creatinine; Female; Fenoldopam; H | 1993 |
Fenoldopam infusion associated with preserving renal function after aortic cross-clamping for aneurysm repair.
Topics: Adult; Age Factors; Aged; Aorta; Aortic Aneurysm, Abdominal; Cardiovascular Surgical Procedures; Dop | 2001 |
The effects of fenoldopam on renal function in patients undergoing elective aortic surgery.
Topics: Aged; Analysis of Variance; Antihypertensive Agents; Aorta; Blood Pressure; Double-Blind Method; Ele | 2002 |
5 other studies available for fenoldopam and Kidney Failure
| Article | Year |
|---|---|
Safety and performance of targeted renal therapy: the Be-RITe! Registry.
Topics: Aged; Aged, 80 and over; Alprostadil; Catheterization; Contrast Media; Creatinine; Drug Delivery Sys | 2009 |
Targeted renal therapy: a potential weapon in the battle against CIN.
Topics: Alprostadil; Catheterization; Contrast Media; Drug Delivery Systems; Equipment Design; Fenoldopam; H | 2009 |
A case series of low-dose fenoldopam in seventy cardiac surgical patients at increased risk of renal dysfunction.
Topics: Aged; Antihypertensive Agents; Cardiac Surgical Procedures; Cardiopulmonary Bypass; Creatinine; Dose | 2003 |
Effects of fenoldopam on renal blood flow and its function in a canine model of rhabdomyolysis.
Topics: Animals; Antihypertensive Agents; Creatinine; Disease Models, Animal; Dogs; Female; Fenoldopam; Glyc | 2003 |
Use of fenoldopam to prevent radiocontrast nephropathy in high-risk patients.
Topics: Aged; Aged, 80 and over; Angiography; Contrast Media; Creatinine; Female; Fenoldopam; Humans; Male; | 2001 |